LUCERNE

E822410

LUCERNE is a large phase III clinical trial evaluating the efficacy and safety of faricimab for the treatment of neovascular (wet) age-related macular degeneration.

All labels observed (1)

Label Occurrences
LUCERNE canonical 1

How this entity was disambiguated

Statements (13)

Predicate Object
instanceOf clinical trial ⓘ
phase III clinical trial ⓘ
evaluates efficacy of faricimab ⓘ
faricimab NERFINISHED ⓘ
safety of faricimab ⓘ
hasConditionCategory age-related macular degeneration GENERATED ⓘ
retinal disease GENERATED ⓘ
hasPhase Phase III ⓘ
hasPrimaryIndication neovascular age-related macular degeneration ⓘ
wet age-related macular degeneration ⓘ
hasTherapeuticArea ophthalmology ⓘ
studies treatment of neovascular (wet) age-related macular degeneration ⓘ
usesIntervention faricimab ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

faricimab → clinicalTrial → LUCERNE ⓘ